CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the...
8 insider purchases on record · latest filing 2023-03-31.
Insiders have also filed 179 sale transactions at CTMX.